NCT00474994View on ClinicalTrials.gov

Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Adult Malignant Fibrous Histiocytoma of BoneDesmoid TumorEndometrial CancerOvarian CancerSarcomaSmall Intestine Cancer
Interventions
DRUG

sunitinib malate

Trial Locations (2)

10021

Memorial Sloan-Kettering Cancer Center, New York

02115

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Dana-Farber Cancer Institute

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00474994 - Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas | Biotech Hunter | Biotech Hunter